Systems and methods for reducing scarring

US9737395B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9737395-B2
Application numberUS-201514751396-A
CountryUS
Kind codeB2
Filing dateJun 26, 2015
Priority dateJun 26, 2015
Publication dateAug 22, 2017
Grant dateAug 22, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods are disclosed to protect a medical device from scarring a body after implanting the device in the body by creating a bonding matrix on a surface of the device; exposing the surface to hyaluronic acid (HA) or polyethylene glycol (PEG); cross linking the HA or PEG; and preventing capsular contracture after implanting the device in the body.

First claim

Opening claim text (preview).

What is claimed is: 1. A method to protect a medical device from scarring a body after implanting the device in the body, comprising: swelling a device shell; allowing hyaluronic acid (HA) to diffuse into a polymer matrix of the shell; cross-linking the HA while the shell is swollen; and deswelling the device shell thereafter. 2. The method of claim 1 , comprising forming an interpenetrating network with the HA. 3. The method of claim 1 , comprising cross-linking the HA to an iso-osmotic state. 4. The method of claim 1 , comprising swelling the device shell with tetrahydrofuran (THF) or dichloromethane (DCM). 5. The method of claim 1 , comprising deswelling with water or saline. 6. The method of claim 1 , comprising cross-linking the HA with divinyl sulfide (DVS) or diglycidyl ether (BDDE). 7. The method of claim 1 , wherein the device comprises an implantable medical device. 8. The method of claim 1 , wherein the device comprises a breast implant, a facial implant, a heart valve, a stent, a graft, a cardiovascular graft, an artificial joint, a rod, a knee portion, a skull plate, cranial facial hardware, a heart part, a pacemaker, an electrical lead, a nerve stimulator, a suture. 9. A method to protect a medical device from scarring a body after implanting the device in the body, comprising: swelling a device shell; allowing hyaluronic acid (HA) to diffuse into a polymer matrix of the shell; cross-linking the HA while the shell is swollen; and deswelling the device shell thereafter; and preventing capsular contracture after implanting the device in the body. 10. The method of claim 9 , wherein the device comprises an implantable medical device. 11. The method of claim 9 , wherein the device comprises a breast implant, a facial implant, a heart valve, a stent, a graft, a cardiovascular graft, an artificial joint, a rod, a knee portion, a skull plate, cranial facial hardware, a heart part, a pacemaker, an electrical lead, a nerve stimulator, a suture. 12. A method to protect a medical device from scarring a body after implanting the device in the body, comprising: exposing a device surface to hyaluronic acid (HA) or polyethylene glycol (PEG); cross linking the HA or PEG; swelling a device shell; allowing HA or PEG to diffuse into a polymer matrix of the shell; and deswelling the device shell thereafter. 13. The method of claim 12 , wherein the device comprises an implantable medical device. 14. The method of claim 12 , wherein the device comprises a breast implant, a facial implant, a heart valve, a stent, a graft, a cardiovascular graft, an artificial joint, a rod, a knee portion, a skull plate, cranial facial hardware, a heart part, a pacemaker, an electrical lead, a nerve stimulator, a suture. 15. The method of claim 12 , comprising cross-linking the HA while the shell is swollen.

Assignees

Inventors

Classifications

  • A61L27/34Primary

    Macromolecular materials · CPC title

  • A61F2/12Primary

    Mammary prostheses · CPC title

  • multilayered, e.g. laminated structures · CPC title

  • Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

  • Means for introducing or releasing pharmaceutical products into the body · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9737395B2 cover?
Systems and methods are disclosed to protect a medical device from scarring a body after implanting the device in the body by creating a bonding matrix on a surface of the device; exposing the surface to hyaluronic acid (HA) or polyethylene glycol (PEG); cross linking the HA or PEG; and preventing capsular contracture after implanting the device in the body.
Who is the assignee on this patent?
Nguyen Phi, Phan Loc, Tran Bao
What technology area does this patent fall under?
Primary CPC classification A61L27/34. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).